Translational Medicine-2013 will bring together representatives from the pharma, government and leading academic research institutions. Together they will discuss on advancement of early stage research to clinical treatments.
We do think of translational research and drug discovery as a one-way street. It all starts with the identification of a molecular mechanism and later on eventually leading to a drug that can specifically target a component. Translational Medicine plays an important role in research and pharmaceutical industry. It can be defined in terms of promoting multidisciplinary interactions between science and medicine to enhance disease research and drug development.
Translational Medicine-2013 will cover current and emerging challenges in the biopharmaceutical industry and strategies for drug development. Current strategies and processes for drug discovery and development within the pharmaceutical industry are contrasted with the adoption of Translational Medicine research strategies. Translational Medicine-2013 considers the requirements of various medical advances in terms of innovative strategic approaches to deliver advances to patients, and the contrasting requirements for effective translation in commercial companies and health services. It will cover integration across scientific, medical and socio-economic disciplines.